Impact of Intrathecal vs Intravenous Dexmedetomidine

Clinical trial NCT06410365 · UNKNOWN

Trial details

NCT number: NCT06410365
Sponsor: Muhammad Ilyas
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Nausea and Vomiting, Postoperative

Start date: 2024-06-01
Primary completion: 2024-10-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.